SANUWAVE Health Inc
OTC:SNWV
Intrinsic Value
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. [ Read More ]
The intrinsic value of one SNWV stock under the Base Case scenario is 0.0762 USD. Compared to the current market price of 0.0216 USD, SANUWAVE Health Inc is Undervalued by 72%.
Valuation Backtest
SANUWAVE Health Inc
Run backtest to discover the historical profit from buying and selling SNWV stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
SANUWAVE Health Inc
Current Assets | 7.4m |
Cash & Short-Term Investments | 1.1m |
Receivables | 3.2m |
Other Current Assets | 3.1m |
Non-Current Assets | 12.9m |
PP&E | 1.1m |
Intangibles | 11.9m |
Current Liabilities | 85.4m |
Accounts Payable | 4.6m |
Accrued Liabilities | 12.5m |
Short-Term Debt | 27.3m |
Other Current Liabilities | 41m |
Non-Current Liabilities | 862k |
Other Non-Current Liabilities | 862k |
Earnings Waterfall
SANUWAVE Health Inc
Revenue
|
18.9m
USD
|
Cost of Revenue
|
-5.6m
USD
|
Gross Profit
|
13.3m
USD
|
Operating Expenses
|
-17.9m
USD
|
Operating Income
|
-4.6m
USD
|
Other Expenses
|
-47.6m
USD
|
Net Income
|
-52.2m
USD
|
Free Cash Flow Analysis
SANUWAVE Health Inc
What is Free Cash Flow?
SNWV Profitability Score
Profitability Due Diligence
SANUWAVE Health Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
SANUWAVE Health Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
SNWV Solvency Score
Solvency Due Diligence
SANUWAVE Health Inc's solvency score is 16/100. The higher the solvency score, the more solvent the company is.
Score
SANUWAVE Health Inc's solvency score is 16/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SNWV Price Targets Summary
SANUWAVE Health Inc
Ownership
SNWV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SNWV Price
SANUWAVE Health Inc
Average Annual Return | -20.86% |
Standard Deviation of Annual Returns | 42.48% |
Max Drawdown | -100% |
Market Capitalization | 24.6m USD |
Shares Outstanding | 1 140 560 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Suwanee, Georgia and currently employs 43 full-time employees. The company went IPO on 2008-11-07. The firm's is focused on regenerative medicine utilizing noninvasive, acoustic shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. The firm's lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. The company intends to apply its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic, plastic/cosmetic and cardiac conditions.
Contact
IPO
Employees
Officers
The intrinsic value of one SNWV stock under the Base Case scenario is 0.0762 USD.
Compared to the current market price of 0.0216 USD, SANUWAVE Health Inc is Undervalued by 72%.